ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.0
  1. ホーム
  2. /反応

Dichloromethane → HCID 86700347、化合物

HRID 879528
ノート
印刷プレビュー

反応式

HRID 879528 の反応式
Br[C:2]1[C:7]([CH:8]([F:10])[F:9])=[CH:6][N:5]=[C:4]([Cl:11])[CH:3]=1.B1(B2OC(C)(C)C(C)(C)O2)OC(C)(C)C(C)(C)O1.C(Cl)Cl.CC([O-])=O.[K+].Br[C:39]1[S:40][C:41]2[C:47]([C:48]3[CH:53]=[CH:52][C:51]([Cl:54])=[CH:50][CH:49]=3)=[C:46]([C@H:55]([O:61][C:62]([CH3:65])([CH3:64])[CH3:63])[C:56]([O:58][CH2:59][CH3:60])=[O:57])[C:45]([CH3:66])=[CH:44][C:42]=2[N:43]=1.C([O-])([O-])=O.[K+].[K+]>O1CCOCC1.CCOC(C)=O.C1C=CC(P(C2C=CC=CC=2)[C-]2C=CC=C2)=CC=1.C1C=CC(P(C2C=CC=CC=2)[C-]2C=CC=C2)=CC=1.Cl[Pd]Cl.[Fe+2]>[C:62]([O:61][C@@H:55]([C:46]1[C:45]([CH3:66])=[CH:44][C:42]2[N:43]=[C:39]([C:2]3[C:7]([CH:8]([F:10])[F:9])=[CH:6][N:5]=[C:4]([Cl:11])[CH:3]=3)[S:40][C:41]=2[C:47]=1[C:48]1[CH:49]=[CH:50][C:51]([Cl:54])=[CH:52][CH:53]=1)[C:56]([O:58][CH2:59][CH3:60])=[O:57])([CH3:63])([CH3:64])[CH3:65]
参加物反応条件実験手順後処理出典と根拠反応ノート

参加物

10

反応物 6

HCID 6344Dichloromethane2 回HCID 11430Potassium CarbonateHCID 517044Potassium AcetateHCID 2733548Bis(pinacolato)diboraneHCID 86700141(S)-ethyl 2-(2-bromo-7-(4-chlorophenyl)-5-methylbenzo[d]thiazol-6-yl)-2-tert-butoxyacetateHCID 867003484-Bromo-2-chloro-5-(difluoromethyl)pyridine

生成物 1

HCID 86700347HCID 86700347、化合物

試薬・触媒・溶媒 3

HCID 44119782Bis(cyclopenta-1,4-dien-1-yl(diphenyl)phosphane);dichloropalladium;iron(2+)触媒2 回HCID 8857Ethyl Acetate溶媒HCID 312751,4-Dioxane溶媒

反応条件

温度
100 °C

実験手順

A microwave vial was charged with 4-bromo-2-chloro-5-(difluoromethyl)pyridine (155 mg, 0.64 mmol), Bis(pinacolato)diboron (179 mg, 0.70 mmol), PdCl2(dppf).CH2Cl2 (55 mg, 0.07 mmol), then KOAc (198 mg, 2.00 mmol). The vial was flushed with argon, diluted with dioxane (4 mL), sealed, then heated to 100° C. for 1 hour. The reaction mixture was allowed to cool to room temperature and then a portion of this cooled solution (1.2 mL, 0.19 mmol) was added to a vial that was charged with (S)-ethyl 2-(2-bromo-7-(4-chlorophenyl)-5-methylbenzo[d]thiazol-6-yl)-2-tert-butoxyacetate (58 mg, 0.12 mmol) and PdCl2(dppf).CH2Cl2 (19 mg, 0.02 mmol). The mixture was diluted with dioxane (0.8 mL) and to this was added 2M aqueous K2CO3 (0.20 mL, 0.40 mmol). The vial was sealed, heated to 100° C. for 1 hour, and then allowed to cool to room temperature. The mixture was diluted with EtOAc, dried over Na2SO4, filtered, and concentrated in vacuo. The crude residue was purified by silica gel column chromatography (0-15% EtOAc/Hex gradient) to afford the desired product. LCMS-ESI+: calc'd C28H27Cl2F2N2O3S: 579.1 (M+H+); Found: 579.1 (M+H+).

後処理

  1. customThe vial was flushed with argon
  2. additiondiluted with dioxane (4 mL)
  3. customsealed
  4. temperatureto cool to room temperature
  5. customThe vial was sealed
  6. temperatureheated to 100° C. for 1 hour
  7. temperatureto cool to room temperature
  8. dry with materialdried over Na2SO4
  9. filtrationfiltered
  10. concentrationconcentrated in vacuo
  11. customThe crude residue was purified by silica gel column chromatography (0-15% EtOAc/Hex gradient)

出典と根拠

ORDレコード
ord-180dd6e65b3442c69aecc7f4da17340f
出典データセット
uspto-grants-2015_03
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US08987250B2

反応ノート

読み込み中…

このページの内容参加物反応条件実験手順後処理出典と根拠反応ノート